Skip to main content

Rep. Dana Rohrabacher Touts Marijuana Accomplishments In Farewell Speech

Outgoing Rep. Dana Rohrabacher (R-CA) reflected on his 30 years of service in Congress in a wide-ranging farewell speech on Wednesday, and he dedicated several minutes to talking about progress he helped achieve on marijuana reform.

“I cannot think of a life I would rather have lived—the highs and the lows, the idealism and the pragmatism, the courage and the weakness, the disappointments, and yes, the joyous outcomes that I have seen here as part of this living institution in its 230 years of legislative service to the people of the United States,” he said.

Rohrabacher, who lost his seat to Democrat Harley Rouda in this month’s midterm election, ran down a list of achievements he was proud of and also defended himself against claims that he was Russian President Vladimir Putin’s “favorite congressman.” About half-way through the speech, which he titled, “Standing Against The Tide,” he turned his attention to cannabis.

The “conservative credentials” that he earned during his time as President Ronald Reagan’s special assistant enabled him to “talk to conservative people throughout the country—and, yes, throughout the House and the Senate—on the issue of cannabis,” Rohrabacher said.

“The fact is, marijuana created an illusion of disruption and of decadence in the American peoples’s minds, because in the late sixties the use of marijuana was so public and it was identified as something with hippies and people who didn’t like American culture. Well, the fact is, cannabis has tremendous service to give to the people of our country who are suffering from various maladies.”

Elderly people suffering from pain or lack of appetite, children with epilepsy and even individuals working to kick opioid addictions can benefit from marijuana, he said on the House floor. Cannabis “is not a gateway door into the use of opiates,” but rather “a way out.”

Finally, Rohrabacher described one of his most well-known legislative accomplishments: sponsoring an amendment that prohibits the Justice Department from using federal funds to interfere in state-legal medical cannabis programs. That amendment, he said, helped a burgeoning legal market balloon into a $6 billion industry.

“That is $6 billion not going to the drug cartels in Mexico. That is $6 billion of which can be spent helping people, rather than trying to put someone in jail for consuming a weed, using all the money for law enforcement, jails, judges’s time and police time, rather than trying to protect the American people. What a waste.

“My colleagues joined me in that. I think that has been a wonderful accomplishment that I am very, very proud of and very grateful that I had the opportunity to be here and express that in debate and to reach out to my fellow congressmen here from both sides of the aisle and mobilize a majority that got that passed so that the federal government cannot supersede state law now when it comes to medical marijuana.”

The congressman closed the 30-minute speech by emphasizing his gratitude for having had the opportunity to serve. As one of the most vocal marijuana reform advocates on the GOP side of the House, Rohrabacher’s absence could potentially complicate bipartisan legislative efforts.

But at the same time, with a new Democratic majority and multiple incoming committee chairs already talking about reform, the chamber could be well-positioned to continue the work that Rohrabacher played a key role in advancing, even in his absence.

GOP Congressman Visits Marijuana Dispensary With Bus Full Of Senior Citizens

Photo courtesy of C-SPAN.

Original Article Source: https://www.marijuanamoment.net/rep-dana-rohrabacher-touts-marijuana-accomplishments-in-farewell-speech/

Comments

Popular posts from this blog

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

Can Medical Marijuana Help Aging Parents With Dementia?

For decades, marijuana, even for medical uses, was demonized or questioned.  When states like Colorado legalized it for recreational use, more studies began to determine provable efficacy for its use as a medicine. The Federal government still classifies marijuana the same way it classifies heroin: harmful and with no medical benefits. Now we can see that this is wrong. When states legalized marijuana, referred to as cannabis here, they had an interest in getting data to see what good it could do. Proving efficacy could increase medical marijuana sales, benefit people who might at least find some medical use, and overall would bring tax dollars into the state coffers. Without funding studies, the Federal government has done very little to demonstrate what good cannabis can do. After all, if the presumption is that it helps nothing, there would be no motivation to determine with scientific data that it does anyone any good. But we have convincing data now about its beneficial use ...

Cannabis Watch: Canopy Growth To Book Charge Of Up To $568 Million As Marijuana Restructuring Continues

Canopy Growth Corp. said early Thursday it was halting a range of operations across three continents and expects its restructuring plans to result in a charge of up to C$800 million (567.9 million) in the fiscal fourth quarter. U.S.-traded shares US:CGC CA:WEED of the cannabis company fell 1.9% in afternoon trading. Canopy said it was selling operations in Africa, curtailing cultivation of hemp in the U.S. and Columbia, and shutting down an indoor production facility in Canada. The announcement will result in 85 job cuts, the company said. “When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn,” Canopy Chief Executive David Klein said in a statement. Read: As cannabis industry stays largely quiet on coronavirus, this CEO has been sounding the alarm Canopy’s restructuring announcement was expected by investors, Cowen analyst Vivien Azer wrote in a note to clients Thursday. Azer rate...